Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder
Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This study evaluates the use of Rhodiola rosea in the treatment of Attention
Deficit/Hyperactivity Disorder (ADHD) in adults. Half of participants will receive Rhodiola
rosea, while the other half will receive placebo.